United States Eye Drops Market to grow at a Steady Rate through 2026
Rising eye care awareness
and technological advancements is expected to drive the United States eye drops
market for the forecast period.
According to TechSci Research report, “United
States Eye Drops Market By Type (Prescription v/s Over-The-Counter) By Drug
Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others) By
Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal
Disorders, Others) By Distribution Channel (Hospitals Pharmacy, Retail
Pharmacy, Online Pharmacy) By End User (Hospitals & Clinics, Homecare,
Others) By Company, By Region, Forecast & Opportunities, 2026”, The
United States eye drops market is expected to witness steady growth for the
next five years. A large population is suffering from several eye disorders.
Some of the disorders can be treated at home and some require treatment from
eye specialist. Eye drops are recommended by ophthalmologist as they treat the
eyes without any pain and are very effective in nature. Some of the common eye
problems are dryness of eye, redness, soreness, refractive errors, itching,
conjunctivitis, glaucoma, eye allergy and retinal disorders. Development of eye
drops for treatment of rare eye disorders is expected to drive the growth of
the eye cares market. Also, the presence of advanced technology to improve the
biocompatibility and physicochemical stability to increase the efficiency and
obtain better results is accelerating the growth of the eye cares market in
United States.
The COVID-19 outbreak across the world which has been
declared as pandemic by World Health Organization has affected countries
adversely. Leading authorities in United States imposed lockdown restrictions
and released a set of precautionary measures to contain the spread of novel
coronavirus. Coronavirus affected patients started suffering from shortness of
breath along with coughing and sneezing. United States authorities increased
the capacity of hospitals as a greater number of patients were getting affected
daily and getting admitted into the hospital facilities. Organizations gave the
facility to employees to work from home which increased the screen time of the
employees. Huge amount of time spent on electronic devices led to irritation
and redness of eyes which is creating the lucrative opportunities for the eye
care market growth.
Browse XX Figures spread
through XX Pages and an in-depth TOC on "United States Eye Drops Market”.
https://www.techsciresearch.com/report/united-states-eye-drops-market/7483.html
United
States eye drops market is segmented into type, drug class, disease indication,
distribution channel, end user, regional distribution, and company. Based on type,
eye drops market is divided into prescription and over-the-counter. The
prescription segment is expected to hold major market share for the forecast
period, 2022-2026 owing to presence of old age population and these drugs are
more effective than its counterpart. These are used for medical treatments,
such as cataract and post-surgery inflammations. Based on end user, market is
majorly categorized into hospitals & clinics, homecare, and others. The
hospitals & clinics segment is expected to dominate the eye drops market as
there is high patient in-flow into the hospital facilities suffering from
different eye-disorders. Favourable government reimbursement policies
encouraging the consumers to avail healthcare facilities is increasing the
market for healthcare sector. Based on drug class, market is fragmented into antiallergy,
anti-inflammatory, antiglaucoma, anti-VEGF and others. The anti-VEGF segment is
expected to hold significant share for the next five years. Increasing
prevalence of dry eye disease in United States is boosting the sale of eye
drops in United States. Based on disease indication, market is divided into dry
eye diseases, glaucoma, eye allergy, eye infections, retinal disorders, and others.
The retinol disorders segment is expected to hold lion’s share for the
predicted period.
Bausch
Health Companies, Inc., Alcon, Inc., Johnson & Johnson, Pfizer, Inc.,
Novartis Pharmaceuticals Corporation, Allergan, Inc. (AbbVie), Bayer
Corporation, Genentech, Inc. (Roche), Akorn, Inc., KC Pharmaceuticals, Inc. are
the leading players operating in United States eye drops market. Manufacturers
are increasingly focusing on research and development process to fuel higher
growth in the market. To meet evolving customer demand with respect to better
efficiency and durability, several eye drops manufacturers are coming up with
their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7483
Customers can also
request for 10% free customization on this report.
“Increasing
prevalence of cataract and retinol disorders in United State is boosting the
eye drops market growth. High adoption of digital devices and surge in
awareness regarding the benefits of eye drops is fostering the demand for eye
drops in United States. Frequent travelling and rising pollution levels along
with poor nutritive consumption is fostering the market growth. Market players
are selling the eye drops through online platforms by offering lucrative
discounts and offers to attract consumers and expand the market reach of their
respective drops is expected to propel the growth of eye drops market until
2026” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
“United States Eye Drops
Market By Type (Prescription v/s Over-The-Counter) By Drug Class (Antiallergy,
Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others) By Disease Indication (Dry
Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others)
By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
By End User (Hospitals & Clinics, Homecare, Others) By Company, By Region,
Forecast & Opportunities, 2026” has
evaluated the future growth potential of United States eye drops market and
provided statistics & information on market size, shares, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the of United States eye
drops market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web:
https://www.techsciresearch.com/